Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.
Press releases published on May 6, 2025

Sarah Clayton Teams Up with Chris Voss to Co-Author SuccessBooks® 'Flip the Script'
JOHANNESBURG, SOUTH AFRICA, May 6, 2025 /EINPresswire.com/ -- SuccessBooks® is thrilled to announce an exciting new collaboration with Sarah Clayton, founder of the Global Empathy Project, who will be co-authoring the forthcoming book, “Flip the Script,” …

G20 Interfaith Forum in Cape Town, South Africa on August 10-14
Ubuntu in Action: Focus on Vulnerable Communities CAPE TOWN, SOUTH AFRICA, May 6, 2025 /EINPresswire.com/ -- The G20 Interfaith Forum (IF20) will hold its major 2025 Forum event from August 10-14 in Cape Town, South Africa. The gathering will bring …

Commemorating the 2025 World Interfaith Harmony Week and Welcoming the African Union as a G20 Member
May 13-14, 2025 Conference on Africa’s Faith Communities in Advancing the Sustainable Development Goals, the AU Agenda 2063 and G20 South Africa’s 2025 Process ADDIS ABABA, ETHIOPIA, May 6, 2025 /EINPresswire.com/ -- The conference will bring together …

IRM’s Dorothy Maseke CFIRM Appointed to the World Economic Forum’s Global Future Council on Natural Capital 2025–2026
IRM announces that Dorothy Maseke CFIRM, Deputy Chair, has been appointed as a Council Member of the WEF’s Global Future Council on Natural Capital for 2025–26 LONDON, UNITED KINGDOM, May 6, 2025 /EINPresswire.com/ -- The Institute of Risk Management ( …

Dundee Precious Metals Declares Dividend
TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) today announced that its Board of Directors has declared a second quarter dividend of US$0.04 per common share. The dividend is payable on July 15, …

Calibre Receives Court Approval for Arrangement with Equinox Gold
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the “Company” or “Calibre”) is pleased to announce that the Supreme Court of British Columbia has granted the final order in connection with the …

Dundee Precious Metals Reports First Quarter 2025 Results
TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or the “Company”) announced its operating and financial results for the first quarter ended March 31, 2025. Highlights (Unless otherwise stated, all monetary figures in …

Exgen Announces Investor Relations Agreement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen”, the “Company”): ExGen is pleased to …

BetterLife Announces Debt Settlements
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …

California Resources Reports First Quarter 2025 Financial and Operating Results
Returned $258 Million to Stakeholders, Maintained Balance Sheet Strength, Delivered Flat Quarter-Over-Quarter Total Net Production Company Reaffirms its 2025 Production, Capital Investment and Adjusted EBITDAX Guidance LONG BEACH, Calif., May 06, 2025 ( …

Stake experts releases The African Geopolitical ATLAS 2025: Conflicting Information, Conflicted Realities
Decision-makers' guide to Africa's information …

Cellectis to Report First Quarter Financial Results on May 12, 2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …

Atico Produces 2.23 Million Pounds of Cu and 1,553 Ounces of Au in First Quarter 2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTCQX: ATCMF) announces its operating results for the three months ended March 31, 2025 from its El Roble mine. Production for …

BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
Advancement of lead candidate BGE-102, an oral, brain-penetrant NLRP3 inhibitor for obesity, with initial clinical data expected 2H25 New strategic collaboration with Lilly ExploR…

Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
ACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction Today LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of …

MacroGenics Announces Date of First Quarter 2025 Financial Results
ROCKVILLE, MD, May 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today …

Supernus Announces First Quarter 2025 Financial Results
First quarter 2025 net sales of Qelbree® increased 44% to $64.7 million, compared to the same period in 2024. First quarter 2025 net sales of GOCOVRI® increased 16% to $30.7 million, compared to the same period in 2024. First quarter 2025 total revenues …

Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
PRT3789 monotherapy and combination with docetaxel escalation enrollment is complete and the Company plans to present updated results in the second half of 2025 Enrollment of the Phase 1 study of Prelude’s once daily, oral SMARCA2 degrader, PRT7732 is …

Keros Therapeutics Reports Recent First Quarter 2025 Financial Results
LEXINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients …

Day One Reports First Quarter 2025 Financial Results and Corporate Progress
OJEMDA™ (tovorafenib) prescriptions grew 16% in Q1 2025 compared to Q4 2024 Achieved Q1 2025 OJEMDA™ (tovorafenib) net product revenue of $30.5 million Ended the first quarter with $473.0 million in cash, cash equivalents and short-term investments Company …